home / stock / atai / atai articles

ATAI Articles, ATAI Life Sciences N.V. - From 10/16/23

Stock Information
Company Name: ATAI Life Sciences N.V.
Stock Symbol: ATAI
Market: NASDAQ
Website: atai.life
Menu
ATAI ATAI Quote ATAI Short ATAI News ATAI Articles ATAI Message Board
Get ATAI Alerts

News, Short Squeeze, Breakout and More Instantly...
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More | Benzinga

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE: CYBN) an...
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More | Benzinga

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary...

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit | Benzinga

NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ:ATAI) ("atai"), a clinical-stage biopharmaceutical company ai...

Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation | Benzinga

Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) has completed its Phase 1 study evaluating proprietary oral transmucosal film (O...
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More | Benzinga

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy...

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More | Benzinga

Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge Billionaire hedge fund and NY Mets own...

Exclusive Insights: How Tech Leaders Are Finding Balance Through Microdosing Psychedelics | Benzinga

Psychedelics are one of the buzziest topics in tech these days. With entrepreneurs vouching for their benefits for creativity, focus and gener...
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More | Benzinga

Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next MAPS Public Benefit Corporation (MAPS PBC), the nonprofi...

Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update | Benzinga

Billionaire hedge fund and NY Mets owner, Steve Cohen amped up his support for psychedelics R&D through a new investment of nearly $1...

atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference | Benzinga

NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ:ATAI) ("atai"), a clinical-stage biopharmaceutical company a...
Previous 10 Next 10